BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 25041270)

  • 1. The spectrum of clinical, hormonal and molecular findings in 280 individuals with nonclassical congenital adrenal hyperplasia caused by mutations of the CYP21A2 gene.
    Livadas S; Dracopoulou M; Dastamani A; Sertedaki A; Maniati-Christidi M; Magiakou AM; Kanaka-Gantenbein C; Chrousos GP; Dacou-Voutetakis C
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):543-9. PubMed ID: 25041270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyperplasia.
    Guarnotta V; Niceta M; Bono M; Marchese S; Fabiano C; Indelicato S; Di Gaudio F; Garofalo P; Giordano C
    J Steroid Biochem Mol Biol; 2020 Apr; 198():105554. PubMed ID: 31805392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in hormonal levels between heterozygous
    Silva RS; Carvalho B; Pedro J; Castro-Correia C; Carvalho D; Carvalho F; Fontoura M
    Arch Endocrinol Metab; 2022 Apr; 66(2):168-175. PubMed ID: 35289513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid Screening Tools Differentiating Nonclassical Congenital Adrenal Hyperplasia and Polycystic Ovary Syndrome.
    Maffazioli GDN; Bachega TASS; Hayashida SAY; Gomes LG; Valassi HPL; Marcondes JAM; Mendonca BB; Baracat EC; Maciel GAR
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32530459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare CYP21A2 haplotype clarifies the phenotype-genotype discrepancy in an Italian patient with Non Classical Congenital Adrenal Hyperplasia (NC-CAH).
    Concolino P
    Mol Biol Rep; 2020 Apr; 47(4):3049-3052. PubMed ID: 32185686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Saho R; Dolzan V; Zerjav Tansek M; Pastorakova A; Petrovic R; Knapkova M; Trebusak Podkrajsek K; Suput Omladic J; Bertok S; Avbelj Stefanija M; Kotnik P; Battelino T; Pribilincova Z; Groselj U
    Front Endocrinol (Lausanne); 2023; 14():1134133. PubMed ID: 37008950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia.
    Schernthaner-Reiter MH; Baumgartner-Parzer S; Egarter HC; Krebs M; Kautzky-Willer A; Kirchheiner K; Luger A; Bayerle-Eder M
    J Sex Med; 2019 Oct; 16(10):1529-1540. PubMed ID: 31447379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital adrenal hyperplasia with homozygous and heterozygous mutations: a rare family case report.
    Cheng T; Liu J; Sun W; Song G; Ma H
    BMC Endocr Disord; 2022 Mar; 22(1):57. PubMed ID: 35255871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the most common CYP21A2 point mutations in a cohort of congenital adrenal hyperplasia patients from Egypt.
    Essawi M; Mazen I; Fawaz L; Hassan H; ElBagoury N; Peter M; Gaafar K; Amer M; Nabil W; Hohmann G; Soliman H; Sippell W
    J Pediatr Endocrinol Metab; 2020 Jul; 33(7):893-900. PubMed ID: 32614782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Spectrum of Genetic Defects in Congenital Adrenal Hyperplasia in the Population of Cyprus: A Retrospective Analysis.
    Neocleous V; Fanis P; Toumba M; Stylianou C; Picolos M; Andreou E; Kyriakou A; Iasonides M; Nicolaou S; Kyriakides TC; Tanteles GA; Skordis N; Phylactou LA
    Horm Metab Res; 2019 Sep; 51(9):586-594. PubMed ID: 31505704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of Clinical and Lab Algorithms for the Identification of Carriers of Mutations in CYP21A2 - A Study of 365 Children and Adolescents.
    Meinel J; Haverkamp T; Wünsche F; Richter-Unruh A
    Exp Clin Endocrinol Diabetes; 2021 Jul; 129(7):492-499. PubMed ID: 32838438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The distribution of intrafamilial CYP21A2 mutant alleles and investigation of clinical features in Turkish children and their siblings in Southeastern Anatolia.
    Karaoglan M
    J Pediatr Endocrinol Metab; 2019 Dec; 32(12):1311-1320. PubMed ID: 31693496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency.
    Xu C; Jia W; Cheng X; Ying H; Chen J; Xu J; Guan Q; Zhou X; Zheng D; Li G; Zhao J
    Mol Genet Genomic Med; 2019 Jun; 7(6):e671. PubMed ID: 30968594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular basis and genotype-phenotype correlations of congenital adrenal hyperplasia (CAH) in Anatolian population.
    Dundar A; Bayramov R; Onal MG; Akkus M; Dogan ME; Kenanoglu S; Cerrah Gunes M; Kazimli U; Ozbek MN; Ercan O; Yildirim R; Celmeli G; Parlak M; Dundar I; Hatipoglu N; Unluhizarci K; Akalin H; Ozkul Y; Saatci C; Dundar M
    Mol Biol Rep; 2019 Aug; 46(4):3677-3690. PubMed ID: 31006099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Characterization of a Cohort of Italian Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.
    Concolino P; Perrucci A; Carrozza C; Urbani A
    Mol Diagn Ther; 2023 Sep; 27(5):621-630. PubMed ID: 37548905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden.
    Sahlander F; Bensing S; Falhammar H
    Front Endocrinol (Lausanne); 2022; 13():1017303. PubMed ID: 36545328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical analysis of 78 patients with nonclassical 21-hydroxylase deficiency.
    Liu E; Luo H; Zhou K; Zhang Y
    Arch Gynecol Obstet; 2023 Sep; 308(3):871-882. PubMed ID: 36773044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel 9 bp deletion (c.1271_1279delGTGCCCGCG) in exon 10 of CYP21A2 gene causing severe congenital adrenal hyperplasia.
    Anastasovska V; Kocova M; Zdraveska N; Stojiljkovic M; Skakic A; Klaassen K; Pavlovic S
    Endocrine; 2021 Jul; 73(1):196-202. PubMed ID: 33715135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid biomarkers for identifying non-classic adrenal hyperplasia due to 21-hydroxylase deficiency in a population of PCOS with suspicious levels of 17OH-progesterone.
    Oriolo C; Fanelli F; Castelli S; Mezzullo M; Altieri P; Corzani F; Pelusi C; Repaci A; Di Dalmazi G; Vicennati V; Baldazzi L; Menabò S; Dormi A; Nardi E; Brillanti G; Pasquali R; Pagotto U; Gambineri A
    J Endocrinol Invest; 2020 Oct; 43(10):1499-1509. PubMed ID: 32236851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia.
    Wang W; Han R; Yang Z; Zheng S; Li H; Wan Z; Qi Y; Sun S; Ye L; Ning G
    J Steroid Biochem Mol Biol; 2021 Jul; 211():105899. PubMed ID: 33864926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.